Ryan Barbara (CIK 1827169) reported 19 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-05). Recent activity: Sell INKT (1,000 shares), Sell INKT (500 shares), Buy INKT (1,629 shares), Buy INKT (1,434 shares), Buy INDV (6,518 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | MiNK Therapeutics, Inc. (INKT) | Director | Sell | 1,000 | $12,800 |
| 2026-06-05 | MiNK Therapeutics, Inc. (INKT) | Director | Sell | 500 | $6,342 |
| 2026-06-02 | MiNK Therapeutics, Inc. (INKT) | Director | Buy | 1,629 | $17,756 |
| 2026-06-02 | MiNK Therapeutics, Inc. (INKT) | Director | Buy | 1,434 | $17,753 |
| 2026-05-14 | Indivior Pharmaceuticals, Inc. (INDV) | Director | Buy | 6,518 | $0 |
| 2026-03-13 | Indivior Pharmaceuticals, Inc. (INDV) | Director | Buy | 8 | $249 |
| 2026-03-11 | Indivior Pharmaceuticals, Inc. (INDV) | Director | Buy | 31 | $1,009 |
| 2026-03-11 | MiNK Therapeutics, Inc. (INKT) | Director | Sell | 200 | $2,034 |
| 2026-03-11 | MiNK Therapeutics, Inc. (INKT) | Director | Sell | 300 | $4,584 |
| 2026-03-11 | MiNK Therapeutics, Inc. (INKT) | Director | Sell | 500 | $7,785 |
| 2026-03-11 | MiNK Therapeutics, Inc. (INKT) | Director | Sell | 500 | $7,650 |
| 2026-03-04 | MiNK Therapeutics, Inc. (INKT) | Director | Sell | 400 | $4,344 |
| 2026-03-04 | MiNK Therapeutics, Inc. (INKT) | Director | Sell | 100 | $1,083 |
| 2026-01-28 | Indivior Pharmaceuticals, Inc. (INDV) | Director | Buy | 3,722 | $0 |
| 2026-01-07 | INDIVIOR PLC (INDV) | Director | Buy | 775 | $27,427 |
| 2025-12-03 | MiNK Therapeutics, Inc. (INKT) | Director | Buy | 1,601 | $17,755 |
| 2025-09-03 | MiNK Therapeutics, Inc. (INKT) | Director | Buy | 1,281 | $17,755 |
| 2025-06-04 | MiNK Therapeutics, Inc. (INKT) | Director | Buy | 2,476 | $17,753 |
| 2025-03-05 | MiNK Therapeutics, Inc. (INKT) | Director | Buy | 2,019 | $17,747 |
Source: SEC Form 4 filings · as of 2026-06-05